Genmab A/SGMABNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
242.96%
↓ 25% vs avg
Percentile
P77
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
325.13%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 242.96% |
| Q3 2025 | 62.05% |
| Q2 2025 | -81.13% |
| Q1 2025 | 483.12% |
| Q4 2024 | -84.91% |
| Q3 2024 | 823.26% |
| Q2 2024 | 0.00% |
| Q1 2024 | -86.60% |
| Q4 2023 | -17.23% |
| Q3 2023 | 471.98% |
| Q2 2023 | -89.17% |
| Q1 2023 | 987.15% |
| Q4 2022 | -84.73% |
| Q3 2022 | 111.67% |
| Q2 2022 | 68.11% |
| Q1 2022 | 206.36% |
| Q4 2021 | -53.24% |
| Q3 2021 | 34.06% |
| Q2 2021 | -76.15% |
| Q1 2021 | 235.16% |
| Q4 2020 | -117.01% |
| Q3 2020 | 5253.19% |
| Q2 2020 | -94.94% |
| Q1 2020 | 1097.42% |
| Q4 2019 | -43.21% |
| Q3 2019 | 60.40% |
| Q2 2019 | -72.81% |
| Q1 2019 | 241.47% |
| Q4 2018 | 193.03% |
| Q3 2018 | -270.05% |
| Q2 2018 | -73.38% |
| Q1 2018 | 89.84% |
| Q4 2017 | 1423.14% |
| Q3 2017 | -97.04% |
| Q2 2017 | -32.08% |
| Q1 2017 | 827.56% |
| Q4 2016 | -150.61% |
| Q3 2016 | -1.84% |
| Q2 2016 | 1724.75% |
| Q1 2016 | -105.39% |